Oncology Clinical Trials in The Bronx, NY
As of August 2026, 126 paid clinical trials are recruiting for Oncology in The Bronx, New York. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in The Bronx
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
127 clinical trials for Oncology
·Clear filters·A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
A Study to Compare Elritercept With Epoetin Alfa to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Top Research Study Locations in The Bronx
Researchers run research studies in The Bronx, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Montefiore Medical Center | Breast Cancer, Coronary Artery Disease, Acute Myeloid Leukemia | 164 |
| Montefiore Medical Center - Moses Campus | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma | 68 |
| Montefiore Medical Center-Einstein Campus | Stage IV Lung Cancer AJCC v8, Lung Non-Small Cell Carcinoma, Stage IIIB Lung Cancer AJCC v8 | 50 |
| Montefiore Medical Center-Weiler Hospital | Metastatic Malignant Solid Neoplasm, Anatomic Stage IV Breast Cancer AJCC v8, Recurrent Endometrial Carcinoma | 18 |
| Albert Einstein College of Medicine | Dementia, Diabetes, HIV (Human Immunodeficiency Virus) | 17 |
| Children's Hospital at Montefiore | Acute Kidney Injury, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia (AML or ANLL) | 16 |
| Jacobi Medical Center | Sickle Cell Disease, Acute Myocardial Infarction (AMI), Cardiovascular Risk | 13 |
| James J. Peters VA Medical Center, Bronx, NY | Spinal Cord Injury, Connectedness, Health | 13 |
| Montefiore Einstein Comprehensive Cancer Center | Colorectal Neoplasms, Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia Refractory | 12 |
| James J Peters VA Medical Center | Lung Non-Small Cell Carcinoma, Recurrent Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8 | 10 |
| James J. Peters VA Medical Center | Spinal Cord Injuries, Blood Pressure Disorders, Castrate-sensitive | 10 |
| Adams Clinical Bronx | Alcohol Use Disorder, Alzheimers Disease, Depressive Disorder, Major | 7 |
| Montefiore Einstein Cancer Center | Advanced Lymphoma, Advanced Solid Tumor, Breast Cancer | 6 |
| Equity Medical | Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Chronic Spontaneous Urticaria (CSU), Non-Segmental Vitiligo (NSV) | 5 |
| Advantage Clinical Trials | Diabetes Mellitus, Type 2, Irritability Associated With Autism Spectrum Disorder, Irritable Bowel Syndrome With Constipation (IBS-C) | 4 |
| GSK Investigational Site | Asthma, Chickenpox, Colonic Neoplasms | 4 |
| Montefiore | Cardiovascular Diseases, Heart Transplant, Heart Valve Diseases | 4 |
| Montefiore Hospital - Moses Campus | ARDS, ARDS (Acute Respiratory Distress Syndrome), Acute Respiratory Distress Syndrome | 4 |
| The Children's Hospital at Montefiore | Duchenne Muscular Dystrophy, Hematopoietic Cell Transplant, High-Risk Neuroblastoma | 4 |
| Clinical Trial Site | Acid Cholesteryl Ester Hydrolase Deficiency, Type 2, Acid Lipase Deficiency, Cholesterol Ester Storage Disease | 3 |
| Equity Medical, LLC | Atopic Dermatitis, Hidradenitis Suppurativa (HS), Severe Alopecia Areata | 3 |
| Montefiore Einstein | ARDS (Acute Respiratory Distress Syndrome), Brain Tumor, Brain Tumor - Metastatic | 3 |
| Montefiore Einstein Medical Center | Diabetes Complications, Diabetes Mellitus, Type 1, HER2-positive Metastatic Breast Cancer | 3 |
| Montefiore Medical Center - Montefiore Medical Park | Esophageal Squamous Cell Cancer, Head and Neck Squamous Cell Cancer, Hormone-receptor-positive Breast Cancer | 3 |
| Montefiore Medical Center- Montefiore Medical Park | Advanced/Metastatic Non-Small Cell Lung Cancer, Cancer of the Prostate, Carcinoma, Non-Small Cell Lung | 3 |
Active & Upcoming Studies in The Bronx (2026)
Recruiting trials in The Bronx grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (188 active studies)
- Testing the Addition of Venetoclax or Gemtuzumab Ozogamicin (GO) to Usual Treatment Regimen (Cytarabine and Daunorubicin, "7+3") for Core Binding Factor Acute Myeloid Leukemia (CBF-AML) to Improve Response (A MYELOMATCH Treatment Trial) · Phase 2 · National Cancer Institute (NCI)
- Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast Cancer · Phase 2 · Montefiore Medical Center
Cardiovascular (40 active studies)
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
Neurology & pain (26 active studies)
- Comparing Pain Improvement for Intravenous Versus Oral Acetaminophen in Acute Pelvic Pain · Phase 4 · Montefiore Medical Center
- A Prospective Study to Evaluate the Efficacy of Iovera Lumbar Medial Branch Cryoneurolysis Versus Radiofrequency Ablation for the Treatment of Chronic Low Back Pain · Montefiore Medical Center
Diabetes & metabolic (18 active studies)
- A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes · Phase 3 · Eli Lilly and Company
- A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event · Phase 2 · Eli Lilly and Company
Mental health & behavior (15 active studies)
- Psilocybin to Treat Depression in Spinal Cord Injury · Phase 1, Phase 2 · James J. Peters Veterans Affairs Medical Center
- A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively · Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company
HIV / STI (14 active studies)
- Cabotegravir & Rilpivirine Antiretroviral Therapy in Pregnancy · International Maternal Pediatric Adolescent AIDS Clinical Trials Group
- Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV · Phase 4 · Albert Einstein College of Medicine
Pediatric (8 active studies)
- A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction · Phase 3 · Bayer
- Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and Schools · Montefiore Medical Center
Vaccines (3 active studies)
- A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease · Phase 2 · Shionogi
- A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease · Phase 3 · Pfizer
Eye & vision (3 active studies)
- Direct Selective Laser Trabeculoplasty (DSLT) for Patients With Glaucoma or Ocular Hypertension Previously Treated With SLT · The New York Eye Surgery Center
- Clarifying the Optimal Application of SLT Therapy Trial · Phase 3 · University of Pittsburgh
Common conditions studied in The Bronx
- Breast Cancer (13 active studies)
- Acute Myeloid Leukemia (12 active studies)
- Heart Failure (8 active studies)
- Asthma (7 active studies)
- Cardiovascular Diseases (7 active studies)
- Non-Small Cell Lung Cancer (7 active studies)
Leading research sponsors in The Bronx
- Montefiore Medical Center
- National Cancer Institute (NCI)
- Children's Oncology Group
- Albert Einstein College of Medicine
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in The Bronx?
There are approximately 558 recruiting clinical trials in The Bronx, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in The Bronx pay participants?
Most recruiting trials in The Bronx compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in The Bronx?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in The Bronx?
The most common conditions under active study in The Bronx include Breast Cancer (13), Acute Myeloid Leukemia (12), Heart Failure (8), Asthma (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in The Bronx?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in The Bronx on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in The Bronx?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in The Bronx?
Recruiting research sites in The Bronx include Montefiore Medical Center, Montefiore Medical Center - Moses Campus, Montefiore Medical Center-Einstein Campus, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in The Bronx right now?
The largest active categories in The Bronx are Cancer & tumors (188), Cardiovascular (40), Neurology & pain (26). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.